91精品在线视频,国产无码日韩一区二区,亚洲av第一页国产精品,九九中文字幕国产,韩国r级中文字幕在线播放

On May 10, 2017, "2017 China Japan exchange conference on formula food for special medical purposes" was held in Beijing. The conference was guided by China Nutrition and health food association, hosted by Beijing Huawei Pharmaceutical Co., Ltd. and hosted by e drug manager magazine.

Invited to attend the meeting were Mr. Ma aining, special researcher of the Counselor's office of the State Council, former deputy director Bian Zhenjia of the State Food and drug administration, grade III staff of China Health Education Center, Professor Yu Jianchun, deputy director of basic surgery of Peking Union Medical College Hospital, Liu xuecong, Secretary general of China Nutrition and health food association, Professor Shi Hanping, chairman of the special medical purpose formula food application Committee of China Nutrition and health food association Mr. Kawaguchi, President of Japan Medical Nutrition Association, and other Chinese and Japanese industry associations, clinical nutrition experts and scholars, and leaders of special medical food industry, talked freely at the meeting, shared their understanding and experience of special medical food, and conducted exchanges and discussions on special medical food industry, so as to jointly help Chinese and Japanese special medical food enterprises explore development opportunities.

China's special medical formula food market has great potential, and enterprises are facing opportunities and challenges.

With China's gradual entry into an aging society and the increasing demand of Chinese people for clinical nutrition, the market potential of Chinese formula food for special medical purposes (special medical food, fsmp) is huge and has attracted extensive attention.

As the host of this meeting, Mr. Tan Yong, the executive producer of e-medicine manager, shared that the special medical food industry has attracted much attention because of its special historical background: first, with the development of compliance, innovation, internationalization and precision medicine, China's pharmaceutical industry has entered a new stage of development, and some pharmaceutical enterprises are transforming into the field of great health; Secondly, the emergence of special medical food has created a new consumption port outside hospitals and pharmacies, which is the independent demand of the public; Third, the state's control of adjuvant drugs and the adjustment of medical insurance policies have also led to the reshuffle and combing of the pharmaceutical industry.

Bian Zhenjia, a special researcher of the Counselor's office of the State Council and former deputy director of the State Food and drug administration, stressed that the change in the treatment concept of clinicians will bring great benefits to the promotion of the field of special medical food, the containment of diseases and the improvement of health.

Mr. Ma aining, a third-class employee of China Health Education Center, thanked the successful holding of this exchange meeting. As an enterprise directly under the organ service bureau of the health and Family Planning Commission, Beijing Huawei Pharmaceutical Co., Ltd. itself undertakes the social responsibility of serving the people's health. This time, Huawei Company has built such an exchange platform in the field of special medical food, which has promoted the exchanges between all parties and received strong recognition and support from all parties.

Mr. Guan Qingwei, chairman of Beijing Huawei Pharmaceutical Co., Ltd., briefly introduced Huawei Company at the meeting and said that Huawei Company will be committed to becoming a resource integrator, innovator and sharer in China's great health field, and is committed to establishing long-term and stable cooperative relations with many customers. In the future, he hopes to cooperate with more enterprises and achieve win-win results in special medical food and other fields.

Since 2015, China's State Food and Drug Administration (CFDA) has promulgated a series of policies and regulations related to special medical food; In April 2017, CFDA established the special food registration management department, opening a new chapter in the registration management of special medical food. The introduction of this series of measures is of positive significance to the development of special medical food industry. However, how to ensure the effectiveness, safety and standardization of products in basic research, formula design, R & D and production, clinical trials and circulation applications in line with the requirements of Chinese administrative regulations has become a common problem faced by enterprises in the industry.

China will strictly supervise the formula food for special medical purposes from five aspects, including the qualification conditions of the applicant.

Mr. Liu xuecong, Secretary General of China Nutrition and health food association, shared in detail the past and present life, core essence and regulatory institutions of China's special medical food related management regulations. He said that the establishment of CFDA's special food registration management department has opened a new chapter in the registration management of special medical food, which will start from the applicant's qualification conditions, review and approval procedures, labeling, clinical trials Strict supervision and management of special foods shall be carried out in five aspects of supervision and inspection. Secretary General Liu also made a prospect for the special medical food industry, and firmly believed that "special medicine is independent and ready to go". The special medical food market is broad, but opportunities and challenges exist at the same time.

Strengthening publicity, implementing policies and developing products are the only way for the development of China's special medical food industry.

Professor Shi Hanping, chairman of the special medical purpose formula food application professional committee of the nutrition and health food association, as the chairman of the tumor nutrition and support treatment professional committee of the China Anti Cancer Association, made a detailed introduction to the development and application of special medical food. He pointed out that nutritional therapy should be another treatment method paying equal attention to surgery, radiotherapy, chemotherapy and other treatments, It should be the basic treatment method or first-line treatment method for patients. It is a real integrated treatment. Strengthening nutrition science popularization publicity, strengthening nutrition professional education, implementing national incentive policies and developing better products are the only way to promote the development of China's special medical food industry. It is hoped that nutrition treatment can be returned to first-line treatment as soon as possible.

Ms. Wang Junjie, the regulatory director of Nestle Health Science Co., Ltd., pointed out in the sharing report that now special medical food has been recognized as a special food and is a special food. There are registration and management measures for special medical food. It is believed that in the future, enteral nutrition drugs will gradually transition to special medical food, and more and more special medical food will be listed to bring good news to the majority of patients.

The application of special medical food in Japan better proves that nutrition management plays an important role in the treatment and rehabilitation of patients.

At the meeting, Mr. Kawaguchi, President of Japan Medical Nutrition Association, shared the current situation and future of food for special medical purposes in Japan, introduced in detail the classification, application and management regulation changes of food for special medical purposes in Japan, and vividly explained the evaluation criteria and research details of viscosity adjusted food, comprehensive nutritional food and other products with pictures and texts, so that participants could truly experience the improvement of quality by Japanese peers.

Professor Miyazawa Jing, a famous clinical nutritionist from Japan, introduced the experience of Japanese special-purpose food in clinical medicine with rich cases. The detailed data and pictures made the participants deeply understand the important position of clinical nutrition management in the treatment and rehabilitation of patients.

At the meeting, clinical nutrition experts and scholars from Japan and leaders of special medical food industry also shared the special medical food and clinical application in Japan.

In addition, participating enterprises also enthusiastically introduced a number of products.

Through this China Japan exchange meeting, Japanese counterparts saw the great potential of China's special medical food market. Chinese counterparts are full of expectations for Japanese high-quality products. They believe that a large number of business opportunities and high-quality products will be bred on such an exchange platform, so that practitioners and Chinese patients can benefit.

Huawei medicine is willing to work with the industry to meet new opportunities and challenges, update ideas, scientific nutrition, improve supply, pay attention to quality, live a healthy life and dream of China!